MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    The spectrum of composite autonomic severity score in SCA1, SCA2 and SCA3 patients

    D. Tamuli, A. Godiyal, A. Jaryal, A. Srivastava, K. Deepak (New Delhi, India)

    Objective: To analyze composite autonomic severity score in patients of spinocerebellar ataxia types 1, 2 and 3. Background: Spinocerebellar ataxia (SCA) is a progressive neurodegenerative…
  • 2017 International Congress

    Steroid-responsive encephalopathy with associated thyroiditis (SREAT) presenting with pure cerebellar ataxia

    P. Termsarasab, Y. Pitakpatapee, S. Frucht, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: To describe two patients with SREAT presenting with progressive cerebellar ataxia. Background: SREAT or Hashimoto’s encephalopathy is an autoimmune encephalopathy typically presenting with rapidly…
  • 2017 International Congress

    Metabolic pattern of acute hemichorea associated with contralateral carotid stenosis

    L. Savsek, A. Andlovic, N. Ozimic, L. Jensterle, P. Tomse, M. Grmek, J. Pretnar Oblak, Z. Pirtosek, M. Trost, M. Kojovic (Celje, Slovenia)

    Objective: To investigate the metabolic pattern of acute hemichorea associated with contralateral carotid artery stenosis and no lesion on structural brain imaging, using brain 18F-FDG-PET.…
  • 2017 International Congress

    Neurofilament light chain levels in cerebrospinal fluid do not discriminate between patients with prion disease and mimics

    B. Roeben, E. Stransky, K. Brockmann, R. Schüle, W. Maetzler, T. Gasser, G. Machetanz (Tübingen, Germany)

    Objective: To determine whether levels of neurofilament light chain (NFL) in cerebrospinal fluid (CSF) are useful to discriminate between patients with prion disease (PrD) and…
  • 2017 International Congress

    Asymmetric Orthostaic Myoclonus – A Case Series

    Y.-c. Tai, J.-c. Tsou, S.-P. Hsu (Kaohsiung City, Taiwan)

    Objective: To present the first case series of asymmetric orthostatic myoclnus and its reversibility along with the improvement of the underlying disease Background: Orthostatic myoclonus…
  • 2017 International Congress

    In vivo evaluation of tau and amyloid pathology in Corticobasal Syndrome

    F. Niccolini, H. Wilson, S. Hirschbichler, G. Pagano, R. Erro, T. Yousaf, A. Whittington, J. Holton, D. Martino, E. Rabiner, R. Gunn, K. Bhatia, M. Politis (London, United Kingdom)

    Objective: To assess in vivo, with molecular imaging the brain distribution of tau aggregates ([18F]AV1451 PET) and β-amyloid depositions ([18F]AV45 PET) in patients with Corticobasal…
  • 2017 International Congress

    Neuroticism and depression is associated with impulse control disorder in Parkinson’s disease: a controlled study

    N. Titova, N. Sotnikova, E. Katunina (Moscow, Russian Federation)

    Objective: Cross-sectional assessment of personality trait, impulsivity, depression and anxiety collected prospectively in Parkinson’s disease (PD) with impulse control disorders (PD-ICD) compared to a matched…
  • 2017 International Congress

    MANF protects dopamine neurons and locomotion defect from Neurotoxin/Human alpha-synuclein-induced progressive Parkinson’s disease models in C.elegans.

    Z. Zhang (Shanghai, China)

    Objective: To study whether Mesencephalic astrocyte-derived neurotrophic factor (MANF) has beneficial effects in parkinson disease and its intracellular mechanisms.  Background: The distinguishing feature of Parkinson’s…
  • 2017 International Congress

    Decisional capacity for Goals of Care in Parkinson’s Disease with Cognitive Concerns

    M. Abu Snineh, R. Camicioli, J. Miyasaki (Jerusalen, Israel)

    Objective: We sought to assess decisional capacity (DC) for Goals of Care (GOC) using the MacArthur Competence Assessment Tool (MacCAT) for Parkinson’s disease (PD) patients…
  • 2017 International Congress

    Validation of Computerised Measures of Executive Functioning for use in Parkinson’s Disease Assessments.

    T. Dominey, C. Carroll, R. Noad, C. Newman, S. Hall (Plymouth, United Kingdom)

    Objective: i. To validate the use of a computerised finger tapping task as a screening measure for Executive Dysfunction (EF) in Parkinson’s Disease (PD), against…
  • « Previous Page
  • 1
  • …
  • 110
  • 111
  • 112
  • 113
  • 114
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Welcome to the MDS Abstracts Site
  • Advanced Search
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley